Full Press Release Details
ROCKVILLE, Md., June 01, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today announced Company management will participate at the following investor conferences:
William Blair 43rd Annual Growth Stock Conference
Thursday, June 8 at 8:00 a.m. Central Time
TD Cowen 2nd Annual Tools/Dx Revolution
Monday, June 26th at 3:10 PM Pacific Time
A live and archived webcast of the William Blair Presentation will be available on the “Events” section of the MaxCyte investor relations website at https://investors.maxcyte.com/.
Spectrum Seismic Collaborative
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley
Consilium Strategic Communications